Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001511164-14-000285
Filing Date
2014-05-16
Accepted
2014-05-16 16:09:10
Documents
13
Period of Report
2014-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K neurokineform10kjan3114clean.htm 10-K 681170
2 EXHIBIT 31.1 ex311.htm EX-31.1 7789
3 EXHIBIT 31.2 ex312.htm EX-31.2 7812
4 EXHIBIT 32.1 ex321.htm EX-32.1 5777
5 EXHIBIT 32.2 ex322.htm EX-32.2 5758
12 IMAGE neurokineform10kjan3114cl001.jpg GRAPHIC 1882
13 IMAGE neurokineform10kjan3114cl003.gif GRAPHIC 266298
  Complete submission text file 0001511164-14-000285.txt   4029678

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT neukf-20140131.xml EX-101.INS 469759
7 XBRL TAXONOMY EXTENSION SCHEMA neukf-20140131.xsd EX-101.SCH 50565
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neukf-20140131_cal.xml EX-101.CAL 2933
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neukf-20140131_def.xml EX-101.DEF 82571
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE neukf-20140131_lab.xml EX-101.LAB 195126
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neukf-20140131_pre.xml EX-101.PRE 169031
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Neurokine Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 333-161157 | Film No.: 14851627
SIC: 2834 Pharmaceutical Preparations